• Return to Headlines

Shares of Portola Pharmace Fall to a New 52-Week Low

By James Quinn

Portola Pharmace (NASDAQ:PTLA) traded today at a new 52-week low of $29.03. This new low was reached on approximately average trading volume as 1.1 million shares traded hands, while the average 30-day volume is approximately 856,000 shares.

Portola Pharmace (NASDAQ:PTLA) has potential upside of 88.2% based on a current price of $30.08 and analysts' consensus price target of $56.60. Portola Pharmace shares should first meet resistance at the 50-day moving average (MA) of $40.00 and find additional resistance at the 200-day MA of $42.84.

Portola Pharmace share prices have moved between a 52-week high of $64.56 and the current low of $29.03 and are currently at $30.08 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.9% while the 200-day MA has slid 0.7%.

Portola Pharmaceuticals, Inc. provides specialty pharmaceutical products. The Company offers novel therapeutics for thrombosis, hematologic disorders, and inflammation. Portola Pharmaceuticals serves customers in the United States.

SmarTrend is monitoring the recent change of momentum in Portola Pharmace. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Portola Pharmace in search of a potential trend change.

Keywords: 52 week high/lows portola pharmace

Ticker(s): PTLA